Werkgroep Cardiologische centra Nederland

CLEAR Harmony 1002-040 (Completed)

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER LONG-TERM SAFETY AND TOLERABILITY STUDY OF ETC-1002 IN PATIENTS WITH HYPERLIPIDEMIA AT HIGH CARDIOVASCULAR RISK WHO ARE NOT ADEQUATELY CONTROLLED BY THEIR LIPID-MODIFYING THERAPY
Medicine
ETC-1002
Population
Primairy prevention cardiovasular disease
Phase
III
Starting year
2015
More information
ClinicalTrials.gov

Director of Study

dr. W.R.M. Hermans (Cardioloog)
Tilburg, ETZ locatie Elisabeth